Correlation between hepatitis B virus DNA levels and liver histology: Is the controversy because of paucity of data?

Journal of Clinical Gastroenterology

Volumn 41, Issue 4, 2007, Pages 339-342

  Verma, Sumita ^a   Thuluvath, Paul J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN;

ADULTHOOD; AMINOTRANSFERASE BLOOD LEVEL; CORRELATION COEFFICIENT; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE TRANSMISSION; EDITORIAL; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; LIVER FIBROSIS; LIVER HISTOLOGY; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RISK FACTOR; VIRUS CARRIER; VIRUS MUTATION;

ADULT; DNA, VIRAL; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER;

EID: 34147132929     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31803238c6     Document Type: Editorial

References (19)

1. Lok AS, McMahon BJ. Chronic hepatitis B: update of recommendations. AASLD Practice Guideline. Hepatology. 2004;39:857-861.
2. McQuillan GM, Townsend TR, Fields HA, et al. Seroepidemiology of hepatitis B virus infection in the United States 1976 to 1980. Am J Med. 1989;87:5S-10S.
3. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000, summary of a workshop. Gastroenterology. 2001;120:1828-1853.
4. McMahon BJ. The natural history of chronic hepatitis B virus infection. Sem Liv Dis. 2004;24(suppl 1):17-21.
5. Hadziyannis SJ, Vassilopoulos D. Immunopathogenesis of hepatitis B e antigen chronic hepatitis B infection. Antiviral Res. 2001;52:91-98.
6. Brunetto MR, Oliveri F, Rocca G, et al. Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen. Hepatololgy. 1989;10:198-202.
7. The EASL Jury. EASL International Consensus Conference on hepatitis B 13-14 September, 2002, Geneva, Switzerland. Consensus statement (short version). J Hepatol. 2003;38:533-540.
8. Liaw YF, Leung N, Guan R, et al. Asian-Pacific consensus update working party on chronic hepatitis B. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update. Liver Int. 2005;25:472-489.
9. Nabuco LC, Villela-Nogueira CA, Perez RM, et al. HBV DNA levels in HBsAg positive blood donors and its relationship with liver histology. J Clin Gastroenterol. 2007;41:194-198.
10. Zavaglia C, Mondazzi L, Maggi G, et al. Are alanine aminotransferase, hepatitis B virus DNA or IgM antibody to hepatitis B core antigen serum levels predictors of histological grading in chronic hepatitis B? Liver. 1997;17:83-87.
11. Yuen MF, Ng IO, Fan ST, et al. Significance of HBV DNA levels in liver histology of HBeAg and Anti-HBe positive patients with chronic hepatitis B. Am J Gastroenterol. 2004;99:2032-2037.
12. Lindh M, Horal P, Dhillon AP, et al. Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat. 2000;7:258-267.
13. Martinot-Peignoux M, Boyer N, Colombat M, et al. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol. 2002;36:543-546.
14. Manesis EK, Papatheodoridis GV, Sevastianos V, et al. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection. Am J Gastroenterol. 2003;98:2261-2267.
15. Chu CJ, Hussain M, Lok AS. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology. 2002;36:1408-1415.
16. Iloeje UH, Yang HI, Su J, et al., Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-In HBV (the REVEAL-HBV) Study Group. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology. 2006;130:678-686.
17. Chen CJ, Yang HI, Su J, et al., REVEAL-HBV Study Group. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65-73.
18. Huo TI, Wu JC, Lee PC, et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology. 1998;28:231-236.
19. McMahon BJ. Chronic carriers of hepatitis B virus who clear hepatitis B surface antigen: are they really "off the hook". Hepatology. 1998;28:265-267.